OnKure Therapeutics

Boulder, United States

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Mar 2026

Post-IPO Equity

Biotechnology Life Science Precision Medicine Therapeutics

Top Investors

RA Capital ManagementBlackRockCormorant Asset ManagementVivo CapitalStepStone Group

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about OnKure Therapeutics

Who are OnKure Therapeutics's investors?

OnKure Therapeutics's investors include RA Capital Management, BlackRock, Cormorant Asset Management, Vivo Capital, StepStone Group.

Where is OnKure Therapeutics headquartered?

OnKure Therapeutics is headquartered in Boulder, United States.

What does OnKure Therapeutics do?

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

What stage is OnKure Therapeutics at?

OnKure Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 27, 2026.

MLA

"OnKure Therapeutics — Funding & Investors." VCBacked, March 27, 2026, https://www.vcbacked.co/company/onkure-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). OnKure Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/onkure-therapeutics

Wikipedia (cite web)

{{cite web |title=OnKure Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/onkure-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 27, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.